Explore more publications!

Press Releases

Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results
From Longevity to AI Powered Health Intelligence - 600and1 Launches New Research
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026
John Muir Health Announces Endowed Medical Directorship in Neurosurgery
Former Lawrence County Health Department Employee Sentenced

Former Lawrence County Health Department Employee Sentenced

PHARMACISTS UNITED FOR TRUTH AND TRANSPARENCY APPLAUDS INTRODUCTION OF BIPARTISAN 'RX ACCESS ACT' FOR MILITARY FAMILIES
Scholars in Medicine Launches Mobile App — A 'Consultant in Your Pocket’ for Medical Practitioners
Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
SupplySide Connect New Jersey 2026: Key Insights for the Ingredients Industry in Health and Wellness Innovation
AAFA Calls on Federal Health Officials to Take Action on Food  Allergies
OneWell Health Care Announces Partnership with AidRx to Transform Medication Management in the Philadelphia Market
Pharma Executives Converge on a Cautious Playbook for Agentic AI
Beyond Ride Connects With Harmony Cares to Close the Gap Between In-Home Care and Medical Appointments
IMRIS and University of Michigan Health Announce First Procedure Performed Using the IMRIS InVision™ Operating Suite
New partnership to fast-track Canadian health technology from innovation to patient care
Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue…

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions